Search research articles
Contact Us
Filters
Showing results (351-360 of 455) with videos related to
Page
of 46
Sort By:
Frontiers in Oncology
|
September 26, 2019
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium
Isabelle Ray-Coquard, Ioana Braicu, Regina Berger, et al.
Gynecologic Oncology
|
October 16, 2012
Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium
Andreas Melmer, Linda Fineder, Claudia Lamina, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 13, 2022
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
January 12, 2025
Evaluation of therapy support through a standardized nursing consultation for patients undergoing oral tumor therapy in gynecological oncology within the prospective CAMPA initiative
Lisa Hirschberg, Franziska Henze, Kerstin Paradies, et al.
International Journal of Cancer
|
October 29, 2011
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer
Frederik Marmé, Thomas Hielscher, Sarah Hug, et al.
International Journal of Cancer
|
July 5, 2020
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients
Konstantina Panoutsopoulou, Margaritis Avgeris, Paraskevi Magkou, et al.
Annals of Surgical Oncology
|
October 12, 2012
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation
Christina Fotopoulou, Rongyu Zang, Murat Gultekin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 23, 2016
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
Philipp Harter, Jalid Sehouli, Alexander Reuss, et al.
BMC Cancer
|
April 5, 2013
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium
Dietmar Pils, Dan Tong, Gudrun Hager, et al.
Archives of Gynecology and Obstetrics
|
December 5, 2020
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
Elena Sultova, C Benedikt Westphalen, Andreas Jung, et al.
Page
of 46
Search research articles
Search
Showing results (351-360 of 455) with videos related to
Sort By:
Page
of 46
Frontiers in Oncology
|
September 26, 2019
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium
Isabelle Ray-Coquard, Ioana Braicu, Regina Berger, et al.
Gynecologic Oncology
|
October 16, 2012
Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium
Andreas Melmer, Linda Fineder, Claudia Lamina, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 13, 2022
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
January 12, 2025
Evaluation of therapy support through a standardized nursing consultation for patients undergoing oral tumor therapy in gynecological oncology within the prospective CAMPA initiative
Lisa Hirschberg, Franziska Henze, Kerstin Paradies, et al.
International Journal of Cancer
|
October 29, 2011
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer
Frederik Marmé, Thomas Hielscher, Sarah Hug, et al.
International Journal of Cancer
|
July 5, 2020
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients
Konstantina Panoutsopoulou, Margaritis Avgeris, Paraskevi Magkou, et al.
Annals of Surgical Oncology
|
October 12, 2012
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation
Christina Fotopoulou, Rongyu Zang, Murat Gultekin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 23, 2016
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
Philipp Harter, Jalid Sehouli, Alexander Reuss, et al.
BMC Cancer
|
April 5, 2013
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium
Dietmar Pils, Dan Tong, Gudrun Hager, et al.
Archives of Gynecology and Obstetrics
|
December 5, 2020
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
Elena Sultova, C Benedikt Westphalen, Andreas Jung, et al.
Page
of 46